Critical reviews in oncology/hematologyFemaleHumansBreast NeoplasmsMeta-Analysis as TopicPoly(ADP-ribose) Polymerase Inhibitors
Effectiveness and safety of PARP inhibitors in breast cancer: An umbrella review of systematic reviews and meta-analyses.
Chih-Chen Tzang, Hui-Wen Wu, Chiao-An Luo, Ewen Shengyao Huang, Wei-Chen Lin, Yan-Hua Chen, Zi-Yi Chang, Yi-Ting Lee, Yuan-Fu Kang, Bor-Show Tzang, Tsai-Ching Hsu
Published: 202610.1016/j.critrevonc.2025.105048
Abstract
BACKGROUND: Breast cancer is a leading cause of cancer-related mortality in women worldwide. Poly(ADP-ribose) polymerase inhibitors (PARPi) have shown efficacy in improving progression-free survival (PFS), particularly in patients with breast cancer…
Preview only. Read the full abstract at the source